Biomarker concentrations are a key determinant measurement in many aspects of the drug discovery and development process. Specific biomarker measurements are key components for discovery, ...
Scientists have developed an enzyme-linked immunosorbent assay (ELISA) technology for detecting blood biomarkers that generates an eye-visible color change reaction and, they claim, is up to 10 times ...
Stanford researchers have developed a new biosensor with the ability to continuously detect and monitor the blood concentration of insulin and glucose in real time. The system, dubbed the Real-time ...
WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The ...
Tecan Group (SIX Swiss Exchange: TECN) announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results